Sciences et Avenir avec AFP, Santé, Cerveau et Psy, 13.12.2017
“La cour d’appel d’Orléans a confirmé pour la première fois la responsabilité du géant pharmaceutique Sanofi dans la malformation d’un enfant dont la mère prenait l’antiépileptique Dépakine, condamnant le groupe à payer près de trois millions d’euros à la famille et à la CPAM (Caisse primaire d’assurance maladie), selon l’arrêt que s’est procuré le 11 décembre 2017 l’AFP. Le groupe pharmaceutique, qui va se pourvoir en cassation, a été condamné à payer plus de deux millions d’euros à la famille, dont une rente à vie à la fille cadette qui présente “un syndrome malformatif général” avec notamment une “anomalie des membres supérieurs”.
… continuez à lireDépakine : la justice condamne Sanofi à verser plus de 3 millions d’euros d’indemnités, sur Sciences et Avenir, 13.12.2017.
DRUG JUSTICE – PHARMACEUTICAL COMPANIES SHOULD PAY FOR THEIR MISTAKES
Campaigning to have Grunenthal and Sanofi face their obligations and to stop hiding behind the protection of European legislation, face their responsibility and their guilt, and pay adequate compensation to the thousands of victims affected by their #drugs.
” We are campaigning to have Grunenthal and Sanofi face their obligations and to stop hiding behind the protection of European legislation, face their responsibility and their guilt, and pay adequate compensation to the thousands of victims affected by their drugs.
The drug thalidomide – marketed for pregnant women suffering with morning sickness – was invented and sold by a German pharmaceutical company called Grunenthal between 1957 and 1961. Thalidomide killed most babies in the womb and those who survived are severely injured and disabled. The drug Epilim (Sodium Valproate) was marketed in 1973 as a drug for Epilepsy and to date has affected approx. 20,000 babies in a similar disastrous way.
Grunenthal has never compensated any British thalidomider. We ask that Grunenthal face their responsibility and give financial compensation to thalidomide damaged people in the UK. Grunenthal’s CEO must sit down with the thalidomide representatives and discuss financial compensation not just for the suffering and pain of living with thalidomide but also for the ongoing extra costs of living with the pain caused by thalidomide “.
Read TO: GRUNENTHAL AND SANOFI – DRUG JUSTICE – PHARMACEUTICAL COMPANIES SHOULD PAY FOR THEIR MISTAKES, 38degrees.org.uk/petitions/ a Campaign created by Mikey Argy – SIGN THE PETITION.
